 |
|
Hye Sun Hyun (Hyun HS), Kyung Hoon Paik (Paik KH), Hee Yeon Cho (Cho HY)
Clin Exp Pediatr. 2013;56(4):159-164. Published online 2013 Apr 22 DOI: https://doi.org/10.3345/kjp.2013.56.4.159
|
|
Citations to this article as recorded by
 Correlation of inflammatory biomarkers with the diversity of Bacteroidaceae, Bifidobacteriaceae, Prevotellaceae and Lactobacillaceae families in the intestinal microbiota of patients with end stage renal disease
Mostafa Asgharian, Pourya Gholizadeh, Hossein Samadi Kafil, Morteza Ghojazadeh, Azam Samadi, Jafar Soleymani, Abolghasem Jouyban, Hamid Tayebi Khosroshahi
Advances in Medical Sciences.2022; 67(2): 304. CrossRef The Efficacy of Lactobacillus-Containing Probiotic Supplementation in Hemodialysis Patients: A Randomized, Double-Blind, Placebo-Controlled Trial
Paik Seong Lim, Hsueh Fang Wang, Mei Chen Lee, Li-Shu Chiu, Ming-Ying Wu, Wui-Chen Chang, Tsai Kun Wu
Journal of Renal Nutrition.2021; 31(2): 189. CrossRef Intestinal microbiota and diabetic kidney diseases: the Role of microbiota and derived metabolites inmodulation of renal inflammation and disease progression
C.M. Mosterd, M. Kanbay, B.J.H. van den Born, D.H. van Raalte, E. Rampanelli
Best Practice & Research Clinical Endocrinology & .2021; 35(3): 101484. CrossRef Chronic Kidney Disease-Associated Itch (CKD-aI) in Children—A Narrative Review
Radomir Reszke, Katarzyna Kiliś-Pstrusińska, Jacek C. Szepietowski
Toxins.2021; 13(7): 450. CrossRef Gut microbiota and chronic kidney disease: evidences and mechanisms that mediate a new communication in the gastrointestinal-renal axis
Natalia Lucía Rukavina Mikusic, Nicolás Martín Kouyoumdzian, Marcelo Roberto Choi
Pflügers Archiv - European Journal of Physiology.2020; 472(3): 303. CrossRef Pilot Study of Probiotic Supplementation on Uremic Toxicity and Inflammatory Cytokines in Chronic Kidney Patients
Cristina T. Roth-Stefanski, Carla Dolenga, Lia S. Nakao, Roberto Pecoits-Filho, Thyago P. de Moraes, Andrea N. Moreno-Amaral
Current Nutrition & Food Science.2020; 16(4): 470. CrossRef Gastrointestinal Microbiota in Patients with Chronic Kidney Disease: A Systematic Review
SeonYoon Chung, Jennifer L Barnes, Kim Schafer Astroth
Advances in Nutrition.2019; 10(5): 888. CrossRef Gut Dysbiosis and the Intestinal Microbiome: Streptococcus thermophilus a Key Probiotic for Reducing Uremia
Luis Vitetta, Hannah Llewellyn, Debbie Oldfield
Microorganisms.2019; 7(8): 228. CrossRef Indoxyl sulfate associates with cardiovascular phenotype in children with chronic kidney disease
Johannes Holle, Uwe Querfeld, Marietta Kirchner, Alexandros Anninos, Jürgen Okun, Daniela Thurn-Valsassina, Aysun Bayazit, Ana Niemirska, Nur Canpolat, Ipek Kaplan Bulut, Ali Duzova, Ali Anarat, Rukshana Shroff, Yelda Bilginer, Salim Caliskan, Cengiz Cand
Pediatric Nephrology.2019; 34(12): 2571. CrossRef Concentrations of representative uraemic toxins in a healthy versus non-dialysis chronic kidney disease paediatric population
Evelien Snauwaert, Wim Van Biesen, Ann Raes, Griet Glorieux, Valerie Van Bogaert, Koen Van Hoeck, Marc Coppens, Sanne Roels, Johan Vande Walle, Sunny Eloot
Nephrology Dialysis Transplantation.2018; 33(6): 978. CrossRef Probiotic Supplementation in Chronic Kidney Disease: A Double-blind, Randomized, Placebo-controlled Trial
Natália A. Borges, Flávia L. Carmo, Milena B. Stockler-Pinto, Jessyca S. de Brito, Carla J. Dolenga, Dennis C. Ferreira, Lia S. Nakao, Alexandre Rosado, Denis Fouque, Denise Mafra
Journal of Renal Nutrition.2018; 28(1): 28. CrossRef Effects of probiotic supplementation on inflammatory biomarkers and uremic toxins in non-dialysis chronic kidney patients: A double-blind, randomized, placebo-controlled trial
Amanda de Faria Barros, Natália A. Borges, Lia Sumie Nakao, Carla J. Dolenga, Flavia Lima do Carmo, Dennis de Carvalho Ferreira, Peter Stenvinkel, Peter Bergman, Bengt Lindholm, Denise Mafra
Journal of Functional Foods.2018; 46: 378. CrossRef p-Cresyl Sulfate
Tessa Gryp, Raymond Vanholder, Mario Vaneechoutte, Griet Glorieux
Toxins.2017; 9(2): 52. CrossRef Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects
Alireza Soleimani, Malihe Zarrati Mojarrad, Fereshteh Bahmani, Mohsen Taghizadeh, Mohammad Ramezani, Maryam Tajabadi-Ebrahimi, Parvaneh Jafari, Ahmad Esmaillzadeh, Zatollah Asemi
Kidney International.2017; 91(2): 435. CrossRef Methods of reducing the level of indoxyl sulfate – one of the most potent protein-bound uremic toxins
Malgorzata Karbowska, Tomasz Kaminski, Dariusz Pawlak
Toxin Reviews.2016; 35(3-4): 171. CrossRef Resistant starch for modulation of gut microbiota: Promising adjuvant therapy for chronic kidney disease patients?
Cristiane Moraes, Natália A. Borges, Denise Mafra
European Journal of Nutrition.2016; 55(5): 1813. CrossRef Gut microbiota and inflammation in chronic kidney disease patients
Denise Mafra, Denis Fouque
Clinical Kidney Journal.2015; 8(3): 332. CrossRef
|